SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000912057-97-011383
Filing Date
1997-03-31
Accepted
1997-03-31 00:00:00
Documents
1
Group Members
FRED A MIDDLETONSANDERLING BIOMEDICAL L.P.SANDERLING III BIOMEDICAL,L.P.SANDERLING III LIMITED PARTNERSHIPSANDERLING VENTURE PARTNERS II, L.P.SANDERLING VENTURE PARTNERS IIISANDERLING VENTURESSANDERLING VENTURES LIMITED, L.P.SANDERLING VENTURES MANAGEMENT
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 SC 13D SC 13D 32857
  Complete submission text file 0000912057-97-011383.txt   34947
Mailing Address 213 TECHNOLOGY DRIVE IRVINE CA 92718
Business Address 213 TECHNOLOGY DR IRVINE CA 92718 7147536100
COCENSYS INC (Subject) CIK: 0000895034 (see all company filings)

IRS No.: 330538836 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-42753 | Film No.: 97570975
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 2730 SAND HILL ROAD, SUITE 250 MENLO PARK CA 94025
SANDERLING VENTURES (Filed by) CIK: 0001036779 (see all company filings)